Table 1 Characteristics of AA and NAA groups
From: The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients
Patient characteristics | No label | Label | p-value |
|---|---|---|---|
(N = 153) | (N = 45) | ||
n (%) | n (%) | ||
Age (years) | |||
Median (range) | 65 (22-92) | 64 (22-90) | 0.48 |
Charlson Comorbidity Indexa | |||
Median (range) | 4 (2-12) | 4 (2-10) | 0.36 |
Sex | |||
Male | 86 (56) | 20 (44) | 0.16 |
Mental health historyb | |||
Yes | 24 (16) | 7 (16) | 0.98 |
Treating unit | |||
Hematology | 93 (61) | 27 (60) | 0.85 |
Medical Oncology | 44 (29) | 12(27) | |
Surgical Oncology | 30 (20) | 8 (18) | 0.51 |
Malignancy type | |||
Leukemia | 29 (19) | 13 (29) | |
Lymphoma | 60 (39) | 17 (38) | |
Solid Malignancy | 27 (18) | 6 (13) | |
Multiple myeloma | |||
Inpatient surgery | |||
Yes | 26 (17) | 9 (20) | 0.87 |
ICU admission | |||
Yes | 39 (26) | 12 (27) | 0.87 |
Infectious episodes | |||
Febrile neutropenia | 70 (21) | 24 (24) | 0.54 |
Gram negative bacteremia | 31 (9) | 12 (12) | |
Gram positive bacteremia | 25 (8) | 6 (6) | |
Polymicrobial bacteremia | 11 (3) | 2 (2) | |
Skin and soft tissue infection | 16 (5) | 10 (10) | |
Pneumonia | 19 (6) | 8 (8) | |
Invasive fungal infection | 18 (6) | 4 (4) | |
Intra-abdominal collection | 13 (4) | 3 (3) | |
Mortality (all-cause) | |||
30 day | 6 (3.9) | 1(2.2) | 0.59 |
60 day | 10 (6.5) | 2 (4.5) | 0.89 |
Length of Stay | |||
Median (range) | 19 (2-151) | 23 (3-157) | 0.4618 |
Readmissions | |||
Median (range) | 2 (0-11) | 3.5 (1-17) | 0.02 |
Readmission with an infectious diagnosis | |||
Yes | 42 (27.5) | 24 (53.3) | 0.01 |